Skip to content
Global sound
Healthy Dialogue

Healthy Dialogue

Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)

· 14 min

Show notes

Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic's Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration.

Related Content:

• Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

Website: edhub.ama-assn.org

Live, last hour: 14,974 songs on 6,527 stations in 145 countries

Discover the world through radio

More ways to discover (7)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
KALS 97.1 FMContinue listening